ArticleBritish journal of cancer2025

Retraction Note: Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis.

V Damiano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.